Skip to content

LoFric® Origo™ 44414 (REF 4441440)Recalls & reported problems

Wellspect AB · Single Use Urinary Catheter with salt solution. LoFric Origo, Tiemann 40cm CH14 / Coudé 16" 14FR, Sterile device. · Class 2

All models of LoFric Origo (12)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07392532122576), received between Jul 21, 2020 and Jul 21, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Insufficient Device Problem Information1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 21, 2020Insufficient Device Problem Information; Insufficient Device Problem Information

    ACCORDING TO THE COMPLAINT, AFTER USE OF THE CATHETER THERE WAS A URETHRAL BLEEDING, AND THE USER WENT TO THE HOSPITAL. INFORMATION OF THE EXTENT OF BLEEDING, IF ONLY MINOR OR MORE SEVERE , OR IF PATIENT WAS HOSPITALISED OR ONLY VISITED A CLINIC FOR ADVICE OR TREATMENT HAS NOT BEEN POSSIBLE TO GET INFORMATION ABOUT ALTHOUGH SEVERAL ATTEMPTS HAS BEEN MADE TO GET INFORMATION. THIS INCIDENT OCCURRED IN (B)(6).

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 10300538 ↗

Other CATHETER, STRAIGHT devices

All CATHETER, STRAIGHT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page